Pallas Health vs HealthRX
Both clinics sit in our top 10, so this page exists for readers already comparing them here. It is not written for search and is not submitted for indexing. Every figure below is read from the clinic's own page, with the date.
26 of the 51 clinics we rank are an affiliate partner. Scores come only from our published methodology. At equal displayed scores, active affiliate partners are listed first. What it changes is which clinic a promoted button points at, and every such link carries a PICK badge in the table so you can see it before you click.
Publishes both the intro price and the ongoing one in the same breath ($139 the first month, then $199) and is one of the few here that will sell you brand-name Mounjaro® alongside compounded options.
from $199/mo
Verified 2026-09-14
PickPublishes every plan length with its total billed, per-month rate and renewal price, and the renewal is lower than the signup price, not higher.
from $99/mo on a 12-month plan ($1,188 billed, $190 month to month)
Verified 2026-09-19
Visit →Affiliate link
| Pallas Health | HealthRX | |
|---|---|---|
| Price | from $199/moTheir page, read 2026-09-14 | from $99/mo on a 12-month plan ($1,188 billed, $190 month to month)Their page, read 2026-09-19 |
| Price shape | first-month-rises | one-ongoing-rate |
| What the price doesn’t say | $199/mo is the ongoing rate, and Pallas publishes it that way itself: its page reads “$139 first month · then $199/mo avg.” Tirzepatide is $179 first month then $299/mo. One fee covers provider care and shipping, with no separate membership charge. | $99/mo is the cheapest of four published tiers, and it needs the 12-month plan ($1,188 billed). Month to month is $190; the 3-month plan is $133/mo and the 6-month $119/mo. HealthRX is one of the few here that prints the per-month rate beside every tier, and its FAQ says renewals bill at or below the rate you signed up at. |
| What it covers | Not published. The page does not say what the figure covers.Their page, read 2026-09-14 | Not published. The page does not say what the figure covers.Their page, read 2026-09-19 |
| Billed on top | Not recorded. We have not found a statement either way.Their page, read 2026-09-14 | Not recorded. We have not found a statement either way.Their page, read 2026-09-19 |
| Commitment | The page does not state whether a term is required. What happens after the first period: Publishes both figures in the same line: “Compounded Semaglutide — $139 first month · then $199/mo avg”, and the same for tirzepatide (“$179 first month · then $299/mo avg”).Their page, read 2026-09-14 | The page does not state whether a term is required. What happens after the first period: Publishes the renewal beside the signup price on its own grid: monthly $190 renews at $165, the 3-month plan's $399 renews at $374, semaglutide $149 first month then $165, tirzepatide $193 then $214. The renewal is LOWER, via a standing $25 credit.Their page, read 2026-09-19 |
| Routes | compounded semaglutide, compounded tirzepatide, brand Mounjaro® | compounded semaglutide, compounded tirzepatide |
| Score | 7.8 | 7.7 |
What one does that the other doesn’t
Pallas Health
Offers brand-name where HealthRX does not.
HealthRX
Nothing Pallas Health does not also offer, on the routes we record.
Who each one suits
Every line below is a difference we can measure, with the field or criterion it comes from. Where a side is empty, nothing in what we record favours it. We would rather say that than invent a reason.
Pallas Health
- Only one of the two offering: brand-name.Basis: published treatments, by drug and route
- Scores clearly higher on transparency (8.5 vs 7.5).Basis: our published scoring rubric
- Scores clearly higher on treatment (8.5 vs 7.5).Basis: our published scoring rubric
HealthRX
- The two entry figures are not comparable: Pallas Health's rises after the first period.Basis: published price terms (introductory rate)
Full write-ups: Pallas Health · HealthRX